Evaluating the Influence of the Prostate Weight on the Morbidity and Mortality of Transvesical Open Prostatectomy: Prospective Analysis of 108 Cases in the Urology-Andrology Department of the Ignace Deen National Hospital in Conakry
Introduction: Open transvesical prostatectomy remains today one of the most effective approaches for the management of benign prostatic hyperplasia despite the fact that, this method is associated with multiple complications. The objective of this study was to evaluate the influence of prostate weight on the morbidity and mortality of transvesical prostatectomy for adenoma in the urology-andrology department of the Ignace Deen National Hospital. Materials and Methods: This was a prospective, longitudinal and analytical study lasting 6 months, from March 1, 2022 to August 31, 2022 including patients admitted and operated on by open transvesical prostatectomy by assessing the influence of prostate weight on the morbidity and mortality of transvesical adenomectomies. Results: 108 patients were included in our study, the average age of our patients was 70 ± 7.7 years, cultivators were the most represented profession with 38.89%, and hypertension was the most represented comorbidity with 75%. 33.06% of cases became complicated and surgical wound infection was the main complication with a frequency of 17.40%. Statistical analysis did not conclude that, the prostate weight does not have a statistically significant influence on the morbidity and mortality of transvesical open prostatectomy for benign prostatic hyperplasia. Conclusion: Prostate weight has no influence on the morbidity and mortality of transvesical prostate adenoma.
References
[1]
Bah, I., Bah, M.B., Barry, M.I.I., Diallo, A., Kante, D., Diallo, T.M.O., et al. (2020) Adénomectomie Prostatique Transvésicale: Résultats et Complications au Service d’Urologie Andrologie de l’Hôpital Ignace Deen, CHU de Conakry. Health Sciences and Diseases, 21, 55-59.
[2]
Vale, L. and Fossion, L. (2020) Endoscopic Transvesical Adenomectomy of the Prostate, a New Minimally Invasive Approach for Large Benign Prostatic Hyperplasia. What Has Our Experience Taught Us? Central European Journal of Urology, 73, 482-489.
[3]
Lahlaidi, K., Ariane, M.M. and Fontaine, E. (2014) Actualités sur la prise en charge de l’hyperplasie bénigne de la prostate. Quel adénome traiter et comment? La Revue de Médecine Interne, 35, 189-195. https://doi.org/10.1016/j.revmed.2013.10.007
[4]
Fourcade, R.O., Picot, M.C., Gaudin, A.F., Texier, N. and Slama, A. (2007) Facteurs déterminant le choix thérapeutique des urologues pour la prise en charge des patients ayant une hypertrophie bénigne de la prostate: L’étude DUO. La Presse Médicale, 36, 755-763. https://doi.org/10.1016/j.lpm.2006.12.027
[5]
Massandé Mouyendi, J., Ndang Ngou Milama, S. and Adandé Menest, E. (2017) Morbidité et mortalité après adénomectomie prostatique transvésicale au Centre Hospitalier Universitaire de Libreville. A propos de 68 cas. Uro’Andro, 1, 361-66.
[6]
Varkarakis, I., Kyriakakis, Z., Delis, A., Protogerou, V. and Deliveliotis, C. (2004) Long-Term Results of Open Transvesical Prostatectomy from a Contemporary Series of Patients. Urology, 64, 306-310. https://doi.org/10.1016/j.urology.2004.03.033
[7]
Diallo, M.B., Diallo, A.T., Sow, K.B., Guirassy, S., Balde, S. and Balde, A. (2001) Les complications précoces de l’adénomectomie prostatique transvésicale au service d’urologie de Conakry: À propos de 96 cas. Annales d’urologie, 35, 120-124. https://doi.org/10.1016/S0003-4401(01)00007-9
[8]
Ghoundale, O., Elharrech, Y., Anzaoui, J.E.L., Abaka, N. and Touiti, D. (2014) Le drainage pelvien après adénometomie prostatique transvésicale reste-il indispensable? African Journal of Urology, 20, 154-157. https://doi.org/10.1016/j.afju.2014.04.002
[9]
Kim, M.S., Jang, W.S., Chung, D.Y., Koh, D.H., Lee, J.S., Goh, H.J. and Choi, Y.D. (2019) Effect of Prostate Gland Weight on the Surgical and Oncological Outcomes of Extraperitoneal Robot-Assisted Radical Prostatectomy. BMC Urology, 19, Article No. 1. https://doi.org/10.1186/s12894-018-0434-4
[10]
Luhiriri, N., Alumeti, D. and Cirimwami, P. (2016) Prise en charge diagnostique et chirurgicale de l’hypertrophie bénigne de la prostate a l’hôpital de panzi-république démocratique du Congo. Revue Africaine d’Urologie et d’Andrologie, 1, 289-293.
[11]
Bagayogo, N.A., Faye, M., Sine, B., Sarr, A., Ndiaye, M., Ndiath, A. and Ndoye, A.K. (2021) Hypertrophie bénigne de la prostate (HBP) géante: Aspects épidémiologiques, cliniques et thérapeutiques. Journal Africain d’Urologie, 27, 49-55. https://doi.org/10.21608/afju.2021.9359
[12]
Ugwumba, F.O., Ozoemena, O.F., Okoh, A.D., Echetabu, K.N. and Mbadiwe, O.M. (2014) Transvesical Prostatectomy in the Management of Benign Prostatic Hyperplasia in a Developing Country. Nigerian Journal of Clinical Practice, 17, 797-801. https://doi.org/10.4103/1119-3077.144402
[13]
Descazeaud, A., Robert, G., Delongchamps, N.B., Cornu, J.N., Saussine, C., Haillot, O. and Comité des troubles mictionnels de l’homme de l’association française d’urologie (2012) Bilan initial, suivi et traitement des troubles mictionnels en rapport avec hyperplasie bénigne de prostate: Recommandations du CTMH de l’AFU. Progrès en Urologie, 22, 977-988. https://doi.org/10.1016/j.purol.2012.10.001
[14]
Kyei, M.Y., Mensah, J.E., Morton, B., Gepi-Attee, S., Klufio, G.O. and Yeboah, E.D. (2012) Surgical Management of BPH in Ghana: A Need to Improve Access to Transurethral Resection of the Prostate. East African Medical Journal, 89, 241-245.
[15]
Anglickis, M., Platkevičius, G., Stulpinas, R., Miklyčiūtė, L., Anglickienė, G., Keina, V. and Gradauskas, A. (2019) Giant Prostatic Hyperplasia and Its Causes. Acta Medica Lituanica, 26, 237-243. https://doi.org/10.6001/actamedica.v26i4.4209
[16]
Botcho, G., Kpatcha, T.M., Tengue, K., Dossouvi, T., Sewa, E.V., Simlawo, K. and Dosseh, E.D. (2018) Morbidité et mortalité après adénomectomies prostatiques par voie transvésicale au CHU Kara (Togo). African Journal of Urology, 24, 353-358. https://doi.org/10.1016/j.afju.2018.01.008
[17]
Tchouane, S., Moyo, J.S. and Binam, F. (1992) La rachianesthésie en orthopédietraumatologie. Médecine d’Afrique Noire, 39, 816-820.
[18]
Halidou, M., Adamou, H., Diongolé, H., Amadou, M.M.I. and Adamou, M. (2015) Prise en charge chirurgicale de l’hypertrophie bénigne de la prostate (HBP): À propos de 123 patients colligés à l’Hôpital National de Zinder (HNZ). Annales de l’Université Abdou Moumouni de Niamey, 2,149-156.
[19]
Coulange, C. (2005) Place actuelle de la chirurgie traditionnelle en France dans le traitement de l’hypertrophie bénigne de la prostate. e-Mémoires de l’Académie Nationale de Chirurgie, 4, 8-11.
[20]
Elkoushy, M.A. and Elhilali, M.M. (2016) Management of Benign Prostatic Hyperplasia Larger than 100 ml: Simple Open Enucleation versus Transurethral Laser Prostatectomy. Current Urology Reports, 17, Article No. 44. https://doi.org/10.1007/s11934-016-0601-7
[21]
Kuntz, R.M. (2006) Current Role of Lasers in the Treatment of Benign Prostatic Hyperplasia (BPH). European Urology, 49, 961-969. https://doi.org/10.1016/j.eururo.2006.03.028
[22]
Ou, R., Deng, X., Yang, W., Wei, X., Chen, H. and Xie, K. (2013) Transurethral Enucleation and Resection of the Prostate vs Transvesical Prostatectomy for Prostate Volumes > 80 ml: A Prospective Randomized Study. BJU international, 112, 239-245. https://doi.org/10.1111/bju.12181
[23]
Kpatcha, T.M., Tchangai, B., Tengue, K., Alassani, F., Botcho, G., Darre, T. and Gnassingbe, K. (2016) Experience with Open Prostatectomy in Lomé, Togo. Open Journal of Urology, 6, 73-79. https://doi.org/10.4236/oju.2016.65014
[24]
Salako, A.A., Badmus, T.A., Owojuyigbe, A.M., David, R.A., Ndegbu, C.U. and Onyeze, C.I. (2016) Open Prostatectomy in the Management of Benign Prostate Hyperplasia in a Developing Economy. Open Journal of Urology, 6, 179-189. https://doi.org/10.4236/oju.2016.612029
[25]
Idowu, N., Raji, S., Amoo, A. and Adeleye-Idowu, S. (2022) Surgical Management of Benign Prostatic Hyperplasia in a Tertiary Health Centre. AlQalam Journal of Medical and Applied Sciences, 5, 606-610.
